BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12588672)

  • 21. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Itchy skin--a clinical problem for haemodialysis patients.
    Wikström B
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v3-7. PubMed ID: 17586843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor analysis of the Beer Sheva Psoriasis Severity Score (BPSS).
    Cohen AD; Van-Dijk D; Naggan L; Vardy DA
    Isr Med Assoc J; 2008 Jun; 10(6):419-23. PubMed ID: 18669137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased.
    Jacobson CC; Kimball AB
    Br J Dermatol; 2004 Aug; 151(2):381-7. PubMed ID: 15327545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and psychological characteristics of patients with psoriasis reporting various frequencies of pruritus.
    Janowski K; Steuden S; Bogaczewicz J
    Int J Dermatol; 2014 Jul; 53(7):820-9. PubMed ID: 24261840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical and psychologic measures are necessary to assess overall psoriasis severity.
    Kirby B; Richards HL; Woo P; Hindle E; Main CJ; Griffiths CE
    J Am Acad Dermatol; 2001 Jul; 45(1):72-6. PubMed ID: 11423838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching.
    Ajayi AA; Kolawole BA; Udoh SJ
    Int J Dermatol; 2004 Dec; 43(12):972-7. PubMed ID: 15569037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
    Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy.
    Bardazzi F; Balestri R; Baldi E; Antonucci A; De Tommaso S; Patrizi A
    Dermatol Ther; 2010; 23 Suppl 1():S14-9. PubMed ID: 20136916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodialysis-related pruritus and associated cutaneous manifestations.
    Dyachenko P; Shustak A; Rozenman D
    Int J Dermatol; 2006 Jun; 45(6):664-7. PubMed ID: 16796623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype?
    Kwon HH; Kwon IH; Youn JI
    Int J Dermatol; 2012 Jan; 51(1):53-8. PubMed ID: 22182378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis.
    Gottlieb A; Feng J; Harrison DJ; Globe D
    J Am Acad Dermatol; 2010 Oct; 63(4):580-6. PubMed ID: 20599294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Itching following burns: epidemiology and predictors.
    Van Loey NE; Bremer M; Faber AW; Middelkoop E; Nieuwenhuis MK
    Br J Dermatol; 2008 Jan; 158(1):95-100. PubMed ID: 17986307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of erythromycin for psoriasis vulgaris.
    Polat M; Lenk N; Yalcin B; Gür G; Tamer E; Artuz F; Alli N
    Clin Exp Dermatol; 2007 May; 32(3):295-7. PubMed ID: 17397353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
    Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
    J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity.
    Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E
    Dermatol Online J; 2015 Oct; 21(10):. PubMed ID: 26632793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographic and clinical correlates of extent of psoriasis during stable disease and during flares in chronic plaque psoriasis.
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2008 Apr; 158(4):721-6. PubMed ID: 18284399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20.
    Richards HL; Fortune DG; Griffiths CE; Main CJ
    J Psychosom Res; 2005 Jan; 58(1):89-96. PubMed ID: 15771875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730.
    Ständer S; Schäfer I; Phan NQ; Blome C; Herberger K; Heigel H; Augustin M
    Dermatology; 2010; 221(3):229-35. PubMed ID: 20924157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
    Reich K; Krüger K; Mössner R; Augustin M
    Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.